Viroptic

Active Ingredient(s): Trifluridine
FDA Approved: * April 10, 1980
Pharm Company: * MONARCH PHARMS
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Viroptic Overview

Trifluridine (also called trifluorothymidine or TFT) is an anti-herpesvirus antiviral drug, used primarily on the eye. It was sold under the trade name Viroptic by Glaxo Wellcome, now merged into GlaxoSmithKline. The brand is now owned by Monarch Pharmaceuticals, which is wholly owned by King Pharmaceuticals. Trifluridine was approved for medical use in 1980.[1] It is also a component of the anti-cancer drug trifluridine/tipiracil, which is taken by mouth. Contents 1 Medic...

Read more Viroptic Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Trifluridine

Recent Viroptic Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Viroptic: (1 result)

Sorted by National Drug Code

• 61570-037 Viroptic 1 g/100ml Ophthalmic Solution by Monarch Pharmaceuticals, Inc

Other drugs which contain Trifluridine or a similar ingredient: (3 results)

• TRIFLURIDINE
• LONSURF Trifluridine + Tipiracil
• TRIFLURIDINE + TIPIRACIL

Related Viroptic Topics: